Cancer Biomedicine UCL

Overview

At the Cancer Biomedicine BSc (Hons) at UCL you'll be taught by world renowned researchers at UCL working at the forefront of cancer research. Your skills and knowledge of this fast-evolving field will be widely relevant to careers in biomedical research, medicine, health science, allied health professions and the pharmaceutical industry.

One in two people in the UK will develop cancer in their lifetime. By 2030, four million people will be living with a cancer diagnosis. Graduates who specialise in cancer will be vital to our ability to diagnose, understand and treat this disease now and in the future.

By studying this exciting Cancer Biomedicine degree, you will learn about molecular biology and cancer genetics, cancer biology and therapeutics, clinical cancer management, and the wider impact of a cancer diagnosis on society. You will also explore how new cancer treatment strategies are designed and tested in clinical trials and how we can personalise cancer treatment for our patients.

The foundation of your career

• Many of our cancer biomedicine graduates go onto master's and PhD level studies and graduate entry medicine. According to the Graduate Outcomes surveys carried out by HESA for the 2018-2022 cohorts, around two-thirds of Cancer Biomedicine BSc graduates chose to progress to further study.

• Cancer Biomedicine graduates also go on to work at the highest levels, with the potential to make a significant contribution within all fields of biomedical sciences, research, and associated professions.

• Of those who progress into work after graduation, destinations have included the UCL Cancer Institute, UCLH, Barts Cancer Institute and Four-Square Healthcare, which specialises in medical supplies. Typical roles might include care work in the healthcare sector, biochemists, and inspection or testing in academic research environments.